Article

Effects of silver nanoparticles on rat hepatic cytochrome P450 enzyme activity

National Nanotechnology Center, National Science and Technology Development Agency, Klong Luang, Pathumthani, Thailand.
Xenobiotica (Impact Factor: 2.2). 03/2012; 42(9):854-62. DOI: 10.3109/00498254.2012.670312
Source: PubMed

ABSTRACT

Silver nanoparticles (AgNPs) are increasingly used in various products and consequentially the potential adverse effects associated with exposure to them are of concern. This study investigated the effects of AgNPs on the hepatic drug-metabolizing enzymes of the cytochrome P450 (CYP) families 1, 2 and 3, using both in vitro and in vivo biological assays. AgNPs were orally administered to Sprague-Dawley rats at various concentrations (0-1000 mg/kg body weight/day) for 2 weeks. No effect was found on the plasma levels of ALT, AST and ALP in all treated rat groups, and no significant change in the activities of CYP1A, CYP2C, CYP2D, CYP2E1 and CYP3A was observed for all tested AgNP doses. The results correlated with the observation that no AgNPs were detected in the liver sections of the tested rats. However, the in vitro system using rat liver microsomes demonstrated a strong inhibition of CYP2C (IC(50) = 28 µg/mL) and CYP2D (IC(50) = 23 µg/mL) activities, but not of CYP1A, CYP2E1 and CYP3A activities (IC(50) > 100 µg/mL) at concentrations up to 100 µg/mL of AgNPs. The inhibitory effect of AgNPs on these CYPs indicates the possibility of the AgNP-drug interaction when co-administered with some medicines and this may cause adverse effects to patients.

2 Followers
 · 
46 Reads
  • Source
    • "For instance, nanosized lipid particles have been shown to intensify the phototoxicity of UV radiation in HDF (Bruge et al., 2013) while nanosized titanium dioxide and polystyrene particles have been reported to induce oxidative stress in human and murine cell lines (Jaeger et al., 2012; Xia et al., 2006). Nanoparticles have also been shown to interact with cellular sensitive sites promoting reactive oxygen species (ROS) production at the mitochondrial level, interfering both with the mitochondrial respiratory chain and cytochrome P450 function (Huerta-Garcia et al., 2014; Kulthong et al., 2012; Periasamy et al., 2014). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Nanostructured lipid carriers (NLC) are widely used for topical delivery of active ingredients into the skin for both local and systemic treatment. But concerns have been raised regarding their potential nanotoxicity. To understand the role of NLC composition in terms of cytotoxicity and pro-oxidant effects, we investigated cell viability and intracellular levels of ROS (reactive oxygen species) production in human dermal fibroblasts (HDF) incubated with five NLC formulations differing in their solid lipid composition. HDF and NLC were also exposed to UVA irradiation in order to evaluate the behavior of NLC under realistic environmental conditions which might promote their instability. Using the Guava via-count assay, all nanoparticles, except for those formulated with Compritol 888 ATO, showed a significant decrease in live cells and a parallel increase in apoptotic or dead cells compared to the control, either before and/or after UVA irradiation (18J/cm(2)). NLC formulated with Geleol™ Mono Diglycerides resulted the most cytotoxic. A similar trend was also observed when intracellular ROS levels were measured in HDF incubated with NLC: there was increased ROS content compared to the control, further exacerbated following UVA. NLC formulated with Dynasan 118 were particularly susceptible to UVA exposure. The results indicate which could be the most suitable candidates for formulating NLC that are biocompatible and non-cytotoxic even when exposed to UVA and hence help direct future choices during the formulation strategies of these delivery systems. Of those tested, Compritol 888 ATO appears to be the best choice.
    Full-text · Article · Sep 2015 · International Journal of Pharmaceutics
  • Source
    • "Park et al. (2010) in an oral 28-day study in mice found 1 mg/kg of bw/day of 42 nm silver nanoparticles to increase alkaline phosphatase and alanine aminotransferase . Kulthong et al. (2012) exposed rats orally to 183 nm silver particles in doses up to 1000 mg/kg of bw/day for 2 weeks, and did not find effects on the investigated parameters: alkaline phosphatase, alanine aminotransferase and cytochrome P450 enzymes. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Orally administered silver has been described to be absorbed in a range of 0.4 to 18% in mammals with a human value of 18%. Based on findings in animals, silver seems to be distributed to all of the organs investigated, with the highest levels being observed in the intestine and stomach. In the skin, silver induces a blue-grey discoloration termed argyria. Excretion occurs via the bile and urine. The following dose-dependent animal toxicity findings have been reported: death, weight loss, hypoactivity, altered neurotransmitter levels, altered liver enzymes, altered blood values, enlarged hearts and immunological effects. Substantial evidence exists suggesting that the effects induced by particulate silver are mediated via silver ions that are released from the particle surface. With the current data regarding toxicity and average human dietary exposure, a Margin of Safety calculation indicates at least a factor of five before a level of concern to the general population is reached.
    Full-text · Article · Nov 2013 · Regulatory Toxicology and Pharmacology
    • "Park et al. (2010) in an oral 28-day study in mice found 1 mg/kg of bw/day of 42 nm silver nanoparticles to increase alkaline phosphatase and alanine aminotransferase . Kulthong et al. (2012) exposed rats orally to 183 nm silver particles in doses up to 1000 mg/kg of bw/day for 2 weeks, and did not find effects on the investigated parameters: alkaline phosphatase, alanine aminotransferase and cytochrome P450 enzymes. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Subacute toxicity of 14 nm nanoparticulate silver (Ag-NP) stabilised with polyvinylpyrrolidone and ionic silver in the form of silver acetate (Ag-acetate) was investigated in four-week-old Wistar rats. Animals received orally by gavage the following: vehicle control (10 ♀, 6 ♂); Ag-NP at doses: 2.25 (8 ♀), 4.5 (8 ♀) or 9 mg/kg bw/day (10 ♀, 6 ♂); or Ag-acetate 9 mg silver/kg bw/day (8 ♀) for 28 days. Clinical, haematolological and biochemical parameters, organ weights, macro- and microscopic pathological changes were investigated. Caecal bacterial phyla and their silver resistance genes were quantified. For the Ag-NP groups, no toxicological effects were recorded. For Ag-acetate, lower body weight gain (day 4-7, 11-14, 14-16, P < 0.05; overall, day 1-28, P < 0.01), increased plasma alkaline phosphatase (P < 0.05), decreased plasma urea (P < 0.05) and lower absolute (P < 0.01) and relative (P < 0.05) thymus weight were recorded. In conclusion, these findings indicate toxicity of 9 mg/kg bw/day ionic silver but not of an equimolar Ag-NP dose. This is in accordance with previously reported data showing that oral Ag-acetate, in comparison with an equimolar dose of Ag-NP, resulted in higher silver plasma and organ concentrations.
    No preview · Article · Oct 2011 · Archives of Toxicology
Show more